Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JW9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,975
Award facts
- Contract value 100% obligated
- $12,974.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,974.50 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes. The contract, executed on January 6, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 7, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is a non-set-aside procurement, indicating it was awarded through full and open competition.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion single-award vehicle running through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an extended IDC with DLA valued at up to $999.999 billion through December 2031. These comprehensive vehicles enable AmerisourceBergen to supply a broad portfolio of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices, to support military healthcare systems globally. Actemra, a biologic immunosuppressant, is used to treat various inflammatory and rheumatologic conditions and represents the type of specialty pharmaceutical commodity the company regularly delivers through its DLA contracts.
Quick answers
Who was awarded contract SPE2DR26F9JW9?
SPE2DR26F9JW9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F9JW9 worth?
The government has obligated $12,975 on SPE2DR26F9JW9.
Is contract SPE2DR26F9JW9 an order under another contract?
Yes. SPE2DR26F9JW9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JW9 competed?
The extent of competition for SPE2DR26F9JW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award